A carregar...
PSA and beyond: alternative prostate cancer biomarkers
BACKGROUND: The use of biomarkers for prostate cancer screening, diagnosis and prognosis has the potential to improve the clinical management of the patients. Owing to inherent limitations of the biomarker prostate-specific antigen (PSA), intensive efforts are currently directed towards a search for...
Na minha lista:
| Publicado no: | Cell Oncol (Dordr) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821699/ https://ncbi.nlm.nih.gov/pubmed/26790878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13402-016-0268-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|